Federated Hermes
PLXP

Federated Hermes’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Federated Hermes’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-743
Closed -$1K – 2317
2022
Q3 		$1K Buy
+743
New +$1.1K ﹤0.01% 2118
2017
Q4 		– Sell
-325
Closed -$2K – 2248
2017
Q3 		$2K Buy
+325
New +$2.08K ﹤0.01% 2059

Other funds holding PLXP

Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Steel Grove Capital Advisors
Steel Grove Capital Advisors Memphis, Tennessee $1.12B AUM 20.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
University of Texas/Texas AM Investment Management Co (UTIMCO)
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Federated Hermes's PLXP Position: Q4 2022 in Review

Federated Hermes sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2022, closing a stake of 743 shares — an estimated $1K sold.

Federated Hermes first reported a position in PLXP in Q3 2017 and held it in 2 quarters. The position peaked at $2K in Q3 2017. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.

  • Federated Hermes reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Federated Hermes sold 743 PLx Pharma Inc. Common Stock shares in Q4 2022, an estimated $1K.
  • Federated Hermes first reported a position in PLx Pharma Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Federated Hermes's PLx Pharma Inc. Common Stock position peaked at $2K in Q3 2017.
  • 41 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2022.

Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.